print ISSN: 2411-3956
Algorithm of examination and management of pregnant women with various risk factors for hypertensive disorders
##common.pageHeaderLogo.altText## Actual Questions of Modern Gynecology and Perinatology

Abstract

The aim of the study was to develop an alqoritm for the examination and management of pregnant women with various risk factors for the development of hypertensive disorders.
Materials and methods of research. 230 pregnant women in the fi rst trimester of pregnancy (up to 15 weeks) were examined. Clinical and anamnestic risk factors for hypertension were studied (age, parity, hypertensive disorders in the past, family history of hypertension, infertility, multiple pregnancies, extragenital diseases, etc.), immunograms (general immunological reactivity of the organism, level of autoantibodies to 12 antigens) ELIS-P-Complex-12 enzyme-linked immunosorbent assay and placental growth factor (PLGF) by the method of enzyme immunoassay. The following indicators of predictive characteristics were determined by statistical
methods: sensitivity (Se), specifi city (Sp), predictive value of absence of sign (PV-) and prognostic value of presence of trait (PV +). Determined the eff ectivenessof various methods of preventing preeclampsia depending on the immunological status of pregnant women using immunoqlobulins. Results. The results of the studies allowed us to identify a number of anamnestic, clinical, laboratory, immunological and instrumental risk factors for the development of preeclampsia. Depending on the presence and combination of these predictors of hypertensive disorders, pregnant women from the first trimester of gestation were allocated to high and low risk groups for the development of PE. Evaluation of the eff ectiveness of therapeutic measures has allowed to develop an algorithm for the examination and management of pregnancy trimester for patients with factors of high and low risk of developing hypertensive disorders.

References

Ghulmiyah L, Sibai B. Maternal mortality from preeclampsia-eclampsiа. Semin Perinatol. 2012; 36(1):56 -59. doi: 10.1053/j.semperi.2011.09.011.

Say L et al. Global Causes of Maternal Death: A WHO Systematic Analysis. The Lancet Global Health. 2014; 2(6):e323-333. doi: 10.2016/S2214109Х(14)70227-Х.

Сидорова И. С., Никитина Н.А., Филиппов О.С. Состояние материнской смертности от преэклампсии и эклампсии в Российской Федерации в 2014 г.Что меняется в процессе анализа? Российский вестник акушера-гинеколога 2015;6:4-11[Sidorova I. S., Nikitina N.A., Filippov O.S. The state of maternal deaths from preeclampsia and eclampsia in the Russian Federation in 2014. What changes in the analysis process? Rossijskij vestnik akusheraginekologa. 2015;6:4-11. (In Russ)] doi: 10. 17116/rosakush20151564-11.

Szczepaniak Chichel L, Tykarski Treatment of arterial hypertension in pregnancy in relation to current guidelines of the Polish Society of Arterial Hypertension from 2011. Ginekol Pol. 2012; 83(10):778-83. https://journals.viamedica.pl/ginekologia_polska/article/view/46130.

Trends in maternal mortality: 1990 to 2015. World Health Orqanization. 2015; 77p. http://apps. who.int/iris/bitstream/10665/194254/1/9789241565141_eng.pdf

Полетаев А.Б., Морозов С.Г. Методы ЭЛИП-Тестов в оценке состояния репродуктивно- www.immunculus.ru/node/36 [Poletaev A.B., Morozov S.G. Metody ELIP-Testov v otsenke sostoyaniya reproduktivnogo zdorov’ya zhenshchin fertil’nogo vozrasta. M. Meditsina. 2001, 16 p. (InRuss)] http://www.immunculus.ru/node/36

Шахбазова Н.А. Клинико-иммунологические особенности течения беременности при гипертензивных состояниях, вызванных беременностью. Акушерство Гинекология Репродукция. 2014; 8(3):11-17 [Shakhbazova N.A. Clinical and immunological features of pregnancy during hypertensive conditions caused by pregnancy. Akusherstvo Ginekologiya Reproduktsiya. 2014; 8 (3): 11-17. (In Russ)].

Яковлева Н.Ю., Васильева Е.Ю., Шелепова Е.С. и др. Изучение динамики концентраций факторов ангиогенеза на протяжении физиологической беременности. Акушерство и гинекология. 2016; 8:49-53 [Yakovleva N.Yu., Vasil’eva E.Yu., Shelepova E.S. i dr. Study of the dynamics of concentrations of angiogenesis factors during physiological pregnancy. Akusherstvo i Ginekologiya. 2016;8: 49-53. (In Russ)] doi: 10.18565/aig.2016.8.49-53.

Chappell L.C., Duckworth S., Seed P.T. et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a pro-spective multicenter study. Circulation 2013, 128(19): 2121-31. doi:10.1161/circulationaha.113.003215

PDF (Русский)
PDF (Русский)

Keywords

preeclampsia, risk factors, autoantibodies, placental growth factor, prevention preeklampsiya, risk faktorları, autoanticismlər, plasentar boy faktoru, profi laktika преэклампсия, факторы риска, аутоантитела, фактор роста плаценты, профилактика